(Q33534641)

27 July 2017

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis (English)

1 reference

27 July 2017

6

1 reference

27 July 2017

Philip M Clarke

1

0 references

Joshua A Salomon

Joshua A Salomon

7

0 references

John Chalmers

John Chalmers

4

0 references

Paul P. Glasziou

Paul Glasziou

2

0 references

Anushka Patel

3

Anushka Patel

1 reference

27 July 2017

Mark Woodward

5

1 reference

PubMed ID

20186272

27 July 2017

ADVANCE Collaborative Group

8

1 reference

PubMed ID

20186272

27 July 2017

language of work or name

English

0 references

publication date

23 February 2010

1 reference

27 July 2017

1 reference

27 July 2017

7

1 reference

27 July 2017

2

1 reference

27 July 2017

e1000236

1 reference

Creative Commons Attribution 4.0 International

27 July 2017

start time

23 February 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Cost-utility analysis of intensive blood glucose control with metformin versus usual care in overweight type 2 diabetes mellitus patients in Beijing, P.R. China

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Economic costs of diabetes in the U.S. In 2007.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Lifetime Risk for Diabetes Mellitus in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Econometric estimation of country-specific hospital costs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Health care expenditures for people with diabetes mellitus, 1992.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Excess costs of medical care for patients with diabetes in a managed care population

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000236

Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation

21 January 2018

2 references

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000236

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826379

Direct medical costs for patients with type 2 diabetes in Sweden.

31 October 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000236

Revealing the cost of Type II diabetes in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000236

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000236

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000236

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000236

Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP)

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20186272

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PMED.1000236

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

PubMed ID

20186272